Literature DB >> 6487364

Two mechanisms of adriamycin-DNA interaction in L1210 cells.

M Potmesil, M Israel, R Silber.   

Abstract

Among the effects exerted by adriamycin (ADR), interaction with DNA is closely related to cytotoxicity. The interaction results in the formation of protein-associated DNA single-strand breaks (PA-SSB) and, at drug levels greater than or equal to 2.8 X 10(-6) M, also in "direct" (nonenzymatic) DNA single-strand breaks (D-SSB). To characterize the two types of DNA lesions, euoxic mouse leukemia L1210 cells were treated with various antioxidant agents in the presence of 2.8 X 10(-6), X 10(-5), or X 10(-4) M concentrations of ADR. The enzymes superoxide dismutase (200 micrograms/ml) or catalase (250 micrograms/ml), the OH' scavengers dimethyl sulfoxide (70 mM) or ethanol (70 mM), and an inhibitor of superoxide production, 2-deoxy-glucose (1 and 10 mM), reduced the frequency of D-SSB to 18.3 to 68.2% of its level in ADR-treated controls, while the frequency of PA-SSB remained unchanged. These observations seem to indicate that ADR-mediated free radicals cause discernible DNA damage in euoxic cells only at very high drug concentrations, greater than the peak plasma level achievable clinically following i.v. bolus. At lower ADR levels, relevant to clinical use, another type of interaction between the drug and DNA prevails, which apparently does not involve a free-radical mechanism.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6487364     DOI: 10.1016/0006-2952(84)90069-8

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  9 in total

1.  Effects of doxorubicin on the sensitivity of L1210 leukemia cells to deformation-associated trauma.

Authors:  L Weiss; R J Bernacki; G Elkin; M Hillman
Journal:  Cell Biophys       Date:  1991-02

Review 2.  Topoisomerase inhibitors. A review of their therapeutic potential in cancer.

Authors:  B K Sinha
Journal:  Drugs       Date:  1995-01       Impact factor: 9.546

Review 3.  Redox control of leukemia: from molecular mechanisms to therapeutic opportunities.

Authors:  Mary E Irwin; Nilsa Rivera-Del Valle; Joya Chandra
Journal:  Antioxid Redox Signal       Date:  2012-09-28       Impact factor: 8.401

4.  Notochord-gut failure of detachment and intestinal atresia.

Authors:  Jamal M Merei
Journal:  Pediatr Surg Int       Date:  2004-04-20       Impact factor: 1.827

5.  Lack of involvement of reactive oxygen in the cytotoxicity of mitoxantrone, CI941 and ametantrone in MCF-7 cells: comparison with doxorubicin.

Authors:  G R Fisher; L H Patterson
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

6.  Effect of adriamycin on heart mitochondrial DNA.

Authors:  C N Ellis; M B Ellis; W S Blakemore
Journal:  Biochem J       Date:  1987-07-01       Impact factor: 3.857

7.  The production of DNA strand breaks in human leukocytes by superoxide anion may involve a metabolic process.

Authors:  H C Birnboim; M Kanabus-Kaminska
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

8.  The role of reductive and oxidative metabolism in the toxicity of mitoxantrone, adriamycin and menadione in human liver derived Hep G2 hepatoma cells.

Authors:  S J Duthie; M H Grant
Journal:  Br J Cancer       Date:  1989-10       Impact factor: 7.640

9.  Peroxiredoxin 3 Has Important Roles on Arsenic Trioxide Induced Apoptosis in Human Acute Promyelocytic Leukemia Cell Line via Hyperoxidation of Mitochondrial Specific Reactive Oxygen Species.

Authors:  Yeung-Chul Mun; Jee Young Ahn; Eun Sun Yoo; Kyoung Eun Lee; Eun Mi Nam; Jungwon Huh; Hyun Ae Woo; Sue Goo Rhee; Chu Myong Seong
Journal:  Mol Cells       Date:  2020-09-30       Impact factor: 5.034

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.